Cytokine Levels Correlate with Immune Cell Infiltration after Anti-VEGF Therapy in Preclinical Mouse Models of Breast Cancer

Plasticity in Tumor-Promoting Inflammation: Impairment of Macrophage Recruitment Evokes a Compensatory Neutrophil Response

(2015) Jessica C. Pahler et al.   NEOPLASIA

The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies

(2009) J. Ozao-Choy et al.   CANCER RESEARCH

Vascular endothelial growth factor-induced chemotaxis and IL-10 from T cells

(2009) Jin-Young Shin et al.   CELLULAR IMMUNOLOGY

Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients

(2009) J. S. Ko et al.   CLINICAL CANCER RESEARCH

Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts

(2009) C. L. Roland et al.   MOLECULAR CANCER THERAPEUTICS

A peptoid antagonist of VEGF Receptor 2 recognizes a ‘hotspot’ in the extracellular domain distinct from the hormone-binding site

(2008) D. Gomika Udugamasooriya et al.   BIOORGANIC & MEDICINAL CHEMISTRY

The pharmacophore of a peptoid VEGF receptor 2 antagonist includes both side chain and main chain residues

(2008) D. Gomika Udugamasooriya et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Vascular Endothelial Growth Factor Receptor 2 Mediates Macrophage Infiltration into Orthotopic Pancreatic Tumors in Mice

(2008) S. P. Dineen et al.   CANCER RESEARCH

A VEGFR2 Antagonist and Other Peptoids Evade Immune Recognition

(2008) John M. Astle et al.   International Journal of Peptide Research and Therapeutics

A Peptoid “Antibody Surrogate” That Antagonizes VEGF Receptor 2 Activity

(2008) D. Gomika Udugamasooriya et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Differential effects of interleukin-1 alpha and beta on interleukin-6 and chemokine synthesis in neurones

(2008) Niki Tsakiri et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

(2008) Scott M. Wilhelm et al.   MOLECULAR CANCER THERAPEUTICS

Evolving Strategies for the Management of Hand-Foot Skin Reaction Associated with the Multitargeted Kinase Inhibitors Sorafenib and Sunitinib

(2008) M. E. Lacouture et al.   ONCOLOGIST

Interferon-γ Conditioning Ex Vivo Generates CD25+CD62L+Foxp3+ Regulatory T Cells That Prevent Allograft Rejection: Potential Avenues for Cellular Therapy

(2008) Gang Feng et al.   TRANSPLANTATION